ZJYL Jin Medical International Ltd.
Jin Medical International (ZJYL) news
Jin Medical International Ltd. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker ZJYL, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Latest Jin Medical International news
We have not published a story on Jin Medical International yet. When there is news, it will appear here.
Jin Medical International annual financials
| Line | FY ended Sep 30, 2025 | FY ended Sep 30, 2024 |
|---|---|---|
| Revenue | $20.7 million | $23.5 million |
| Research and development | $1.6 million | $1.5 million |
| Net income (loss) | $1.2 million | $3.7 million |
| Cash from operations | $2.9 million | -$1.2 million |
| Cash and equivalents | $7.5 million | $8.1 million |
| Short-term investments | $22.2 million | $18.6 million |
Questions about Jin Medical International
What is the ticker symbol of Jin Medical International?
Jin Medical International Ltd. trades under the ticker ZJYL on NASDAQ.
Where is Jin Medical International listed?
Jin Medical International Ltd. is listed on NASDAQ.
Which country or territory is Jin Medical International listed under?
Our directory records Jin Medical International Ltd. under United States.
Does aibio.space cover Jin Medical International?
aibio.space lists Jin Medical International Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.
What was Jin Medical International's revenue last year?
$20.7 million for the fiscal year ended Sep 30, 2025, as reported to the SEC.
Is Jin Medical International profitable?
Jin Medical International Ltd. reported net income of $1.2 million for the fiscal year ended Sep 30, 2025, and generated $2.9 million of cash from operations, per its annual report to the SEC.
How much does Jin Medical International spend on research and development?
$1.6 million in the fiscal year ended Sep 30, 2025, per its annual report.
How much cash does Jin Medical International have?
$29.6 million in cash and short-term investments at Sep 30, 2025, per its 20-F.
Investor discussion: Jin Medical International
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Capital-markets timeline
Stock chart
Listing details
- Company
- Jin Medical International Ltd.
- Ticker
- ZJYL
- Listing
- NASDAQ
- Country or territory
- United States
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction
aibio